Toxicity following high-dose salvage radiotherapy after radical prostatectomy

BJU International

Volumn 99, Issue 3, 2007, Pages 529-533

  Jung, Charlie ^a   Cookson, Michael S ^a   Chang, Sam S ^a   Smith Jr , Joseph A ^a   Dietrich, Mary S ^a   Teng, Ming ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adverse effect; Prostatectomy; Prostatic neoplasms; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DIARRHEA; GASTROINTESTINAL TOXICITY; HUMAN; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD; PRIORITY JOURNAL; PROCTITIS; PROSTATECTOMY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION SICKNESS; RETROSPECTIVE STUDY; SALVAGE THERAPY; SCORING SYSTEM; UROGENITAL TRACT DISEASE;

AGED; DIARRHEA; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROCTITIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SALVAGE THERAPY;

EID: 33846932097     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06661.x     Document Type: Article

References (20)

1. Stephenson AJ, Shariat SF, Zelefsky MJ et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 2004; 291: 1325-32
2. Maier J, Forman J, Tekyi-Mensah S, Bolton S, Patel R, Pontes JE. Salvage radiation for a rising PSA following radical prostatectomy. Urol Oncol 2004; 22: 50-6
3. Macdonald OK, Schild SE, Vora SA et al. Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy. J Urol 2003; 170: 1833-7
4. Tsien C, Griffith KA, Sandler HM, et al. Long-term results of three-dimensional conformal adjuvant and salvage radiotherapy after radical prostatectomy. Urology 2003; 62: 93-8
5. Liauw SL, Webster WS, Pistenmaa DA, Roehrborn CG. Salvage radiotherapy for biochemical failure of radical prostatectomy: a single-institution experience. Urology 2003; 61: 1204-10
6. Katz MS, Zelefsky MJ, Venkatraman ES, Fuks Z, Hummer A, Leibel SA. Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer. J Clin Oncol 2003; 21: 483-9
7. Song DY, Thompson TL, Ramakrishnan V et al. Salvage radiotherapy for rising or persistent PSA after radical prostatectomy. Urology 2002; 60: 281-7
8. Choo R, Hruby G, Hong J et al. (IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy. Int J Radiat Oncol Biol Phys 2002; 53: 269-76
9. Chawla AK, Thakral HK, Zietman AL, Shipley WU. Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma. analysis of efficacy and prognostic factors. Urology 2002; 59: 726-31
10. Leventis AK, Shariat SF, Kattan MW, Butler EB, Wheeler TM, Slawin KM. Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2001; 19: 1030-9
11. Anscher MS, Clough R, Dodge R. Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years. Int J Radiat Oncol Biol Phys 2000; 48: 369-75
12. Pisansky TM, Kozelsky TF, Myers RP et al. Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. J Urol 2000; 163: 845-50
13. Teh BS, Mai W, Augspurger ME et al. Intensity modulated radiation therapy (IMRT) following prostatectomy: more favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer. Int J Radiat Oncol Biol Phys 2001; 49: 465-72
14. Zelefsky MJ, Aschkenasy E, Kelsen S, Leibel SA. Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 1997; 39: 327-33
15. Cozzarini C, Fiorino C, Ceresoli GL et al. Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy). Int J Radiat Oncol Biol Phys 2003; 55: 688-94
16. Lee CM, Lee RJ, Handrahan DL, Sause WT. Comparison of late rectal toxicity from conventional versus three-dimensional conformal radiotherapy for prostate cancer: analysis of clinical and dosimetric factors. Urology 2005; 65: 114-9
17. Kuban D, Pollack A, Huang E et al. Hazards of dose escalation in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2003; 57: 1260-8
18. Pollack A, Zagars GK, Starkschall G et al. Prostate cancer radiation dose response. results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002; 53: 1097-105
19. Zelefsky MJ, Leibel SA, Gaudin PB et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998; 41: 491-500
20. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992; 148: 1549-57